ExonHit Therapeutics S.A. (Alternext: ALEHT), a drug and diagnostic discovery company, announces today the availability of its new SpliceArray? for use in studying mouse models of human disease. These SpliceArrayTM products help our clients accelerate and refine their therapeutic target discovery and validation efforts. (more…)
Researchers at the Texas A&M Health Science Center Institute of Biosciences and Technology, and the University of Edinburgh have uncovered how a bacterial pathogen interacts with the blood coagulation protein fibrinogen to cause methicillin-resistant Staphylococcus aureus (MRSA) infections, a finding that could aid in developing therapeutics against the potentially deadly disease. (more…)
Boston Interactive, a Boston-based web design and interactive marketing firm, is pleased to announce the launch of the new website for Fitzgerald Industries International (www.fitzgerald-fii.com), a leading worldwide supplier of antigens and antibodies to companies and research institutions. (more…)
More than 11% of children nationwide, or about one in nine, had no health coverage in 2007, according to a new Families USA analysis of U.S. Census Bureau data, the Boston Globe reports. The number of U.S. (more…)
